The Relationship between Metabolic Parameters, Cardiac Parameters and MIC-1/GDF15 in Obese Children

Abstract

Objective: Childhood obesity which is a predictor of adulthood obesity is associated with type 2 diabetes, metabolic syndrome, dyslipidemia, coronary artery diseases and subclinical inflammation. Growth differentiation factor-15, also known as macrophage inhibitory cytokine-1 (MIC-1/GDF15) is a member of the transforming growth factor- β super family and increases during inflammatory states. Adults with obesity have increased serum concentrations of MIC-1/GDF15. MIC-1/GDF15 is associated with cardio metabolic risk in adults.

Design: Identification of obese children at higher risk for cardio metabolic complications is important. The relations of MIC-1/GDF15 to parameters of obesity in children have never been studied.

Methods: We measured serum MIC-1/GDF15 concentration in obese children by ELİSA and evaluated its relationship with anthropometric, biochemical and echocardiographic parameters.

Results: No significant difference in serum MIC-1/GDF15 between normal-weight and obese children was observed. MIC-1/GDF15 was positively correlated with CRP, ALT and aortic dimension when normal-weight and obese children were analyzed together.

Conclusions: MIC-1/GDF15 may provide a link between childhood obesity and cardio metabolic complications that will occur in time course. Further work would be required to find out if MIC-1/GDF15 has any role in the early inflammatory, cardiac and metabolic changes in childhood obesity.

Key words

obesity - MIC-1/GDF15 - inflammation - cardiovascular risk management

• References

• 1 Kelishadi R, Azizi-Soleiman F. Controlling childhood obesity: A systematic review on strategies and challenges. Journal of Research in Medical Sciences : The Official Journal of Isfahan University of Medical Sciences 2014; 19: 993-1008
• 2 Gupta N, Goel K, Shah P et al. Childhood Obesity in Developing Countries: Epidemiology, Determinants, and Prevention. Endocrine Reviews 2012; 33: 48-70
• 3 Schipper HS, Nuboer R, Prop S et al. Systemic inflammation in childhood obesity: circulating inflammatory mediators and activated CD14++ monocytes. Diabetologia 2012; 55: 2800
• 4 Bootcov MR, Bauskin AR, Valenzuela SM et al. MIC-1, a novel macrophage inhibitory cytokine, is a divergent member of the TGF-beta superfamily. Proceedings of the National Academy of Sciences of the United States of America 1977; 94: 11514-11519
• 5 Karczewska-Kupczewska M, Kowalska I, Nikolajuk A et al. Hyperinsulinemia acutely increases serum macrophage inhibitory cytokine-1 concentration in anorexia nervosa and obesity. Clinical Endocrinology 2012; 76: 46-50
• 6 Dostálová I, Roubícek T, Bártlová M et al. Increased serum concentrations of macrophage inhibitory cytokine-1 in patients with obesity and type 2 diabetes mellitus: the influence of very low calorie diet. European Journal of Endocrinology 2009; 161: 397-404
• 7 Johnen H, Lin S, Kuffner T et al. Tumor-induced anorexia and weight loss are mediated by the TGF-beta superfamily cytokine MIC-1. Nat Med 2007; 13: 1333-1340
• 8 Macia L, Tsai VW, Nguyen AD et al. Macrophage inhibitory cytokine 1 (MIC-1/GDF15) decreases food intake, body weight and improves glucose tolerance in mice on normal & obesogenic diets. PLoS One 2012; 7: e34868
• 9 Schopfer DW, Ku IA, Regan M et al Growth differentiation factor 15 and cardiovascular events in patients with stable ischemic heart disease (The Heart and Soul Study). American Heart Journal 2014; 167: 186-192
• 10 Brown DA, Moore J, Johnen H et al. Serum macrophage inhibitory cytokine 1 in rheumatoid arthritis: a potential marker of erosive joint destruction. Arthritis and Rheumatism 2007; 56: 753-764
• 11 Breit SN, Johnen H, Cook AD et al. The TGF-beta superfamily cytokine, MIC-1/GDF15: a pleotrophic cytokine with roles in inflammation, cancer and metabolism. Growth factors 2011; 29: 187-195
• 12 Adela R, Banerjee SK. GDF-15 as a Target and Biomarker for Diabetes and Cardiovascular Diseases: A Translational Prospective. Journal of Diabetes Research 2015 2015, Article ID 490842, 14
• 13 Chrysovergis K. NAG-1/GDF-15 prevents obesity by increasing thermogenesis, lipolysis and oxidative metabolism. Int J Obes (Lond) 2014; 38: 1555-1564
• 14 Ding Q, Mracek T, Gonzalez-Muniesa P et al. Identification of macrophage inhibitory cytokine-1 in adipose tissue and its secretion as an adipokine by human adipocytes. Endocrinology 2009; 150: 1688-1696
• 15 Wiklund FE, Bennet AM, Magnusson PKE et al. Macrophage inhibitory cytokine-1 (MIC-1/GDF15): a new marker of all-cause mortality. Aging Cell 2010; 9: 1057-1064
• 16 Simm A, Nass N, Bartling B et al. Potential biomarkers of ageing. Biological Chemistry 2008; 389: 257-265
• 17 Kempf T, Guba-Quint A, Torgerson J et al. Growth differentiation factor 15 predicts future insulin resistance and impaired glucose control in obese nondiabetic individuals: results from the XENDOS trial. Eur J Endocrinol 2012; 167: 671-678
• 18 Kempf T, von Haehling S, Peter T et al. Prognostic utility of growth differentiation factor-15 in patients with chronic heart failure. J Am CollCardiol 2007; 50: 1054-1060
• 19 Kempf T, Eden M, Strelau J et al. The transforming growth factor-beta superfamily member growth-differentiation factor- 15 protects the heart from ischemia/reperfusion injury. Circulation Research 2006; 98: 351-360
• 20 Wollert KC, Kempf T. Growth differentiation factor 15 in heart failure: an update. Current Heart Failure Reports 2012; 9: 337-345